Teva settles further price-fixing lawsuits in the US

Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) has settled another lawsuit alleging price fixing in the US. Teva will pay $450 million in settlements approved by the court in the US, one of $425 million and the other of $25…